Back

Weekly Journal Scan: An EPIC comparison of edoxaban vs. dual antithrombotic therapy in atrial fibrillation and stable coronary artery disease

European Heart Journal

4 December 2024
Organised by: Logo
Read full article
ESC Journals

Contributors

Giovanna Liuzzo
Giovanna Liuzzo

Author

IRCCS Foundation Agostino Gemelli University Hospital Rome , Italy

Carlo Patrono
Carlo Patrono

Author

You may be interested in
thumbnail
Congress Presentation
Safety and efficacy of edoxaban monotherapy vs dual antithrombotic therapy in patients with stable coronary artery disease and non-valvular atrial fibrillation: a systematic review and meta-analysis
1 September 2025
thumbnail
Congress Session
Advancing heart failure diagnosis and management: insights from hemodynamics, inflammation, and emerging therapies
19 May 2025
thumbnail
Congress Session
Update on antiarrhythmic therapy
31 March 2025
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources